Page 65 - e-book CPG - Bipolar Disorder
P. 65

CLINICAL PRACTICE GUIDELINES              MANAGEMENT OF BIPOLAR DISORDER (2ND ED.)



                         For long acting injectable, consider  reduce the dose to 300mg once   with dose of 400mg once monthly


                REMARKS     monthly if there are adverse reactions








                COMMON/SIGNIFICANT   ADVERSE EFFECTS   GI: Nausea, vomiting,   constipation, xerostomia   ENT: tinnitus   Endocrine and metabolic:   weight gain,   hypertriglyceridaemia,  hypercholesterolaemia,     hyperglycaemia   CNS: drowsiness,  extrapyramidal reaction,   headache, insomnia  Hematologic: neutropenia        CNS









                HEPATIC DOSE   No dosage adjustment   necessary   Child-Pugh class C:   Use is contraindicated   Child-Pugh class C:   Use not recommended   51







                RENAL DOSE   No dosage   adjustment   necessary   No dosage   adjustment   necessary   CrCl <30 ml/min:   Use not   recommended







                DOSING GUIDE   Acute mania or episodes with   mixed features, acute  hypomania and maintenance   treatment   Oral -   10 - 15 mg once daily; increase  dose in 5 - 10mg/day increment   at intervals of >1 week   (Max dose: 30 mg/day)   LAI -   400 mg once monthly  Acute mania or episodes with   mixed features   Oral











                 MEDICATION   ANTIPSYCHOTICS   Aripiprazole   Asenapine   Cariprazine



                                          51
   60   61   62   63   64   65   66   67   68   69   70